Comparative Safety of Common Immunosuppressant Therapies in Systemic Lupus Erythematosus: A Target Trial Emulation Study

Study limitation reported by the research below: “All patients with lupus nephritis were excluded, so findings apply only to non-renal SLE and should not be extrapolated to more severe or nephritis-predominant disease.”